Fahad Khaliq/X
Jan 7, 2026, 08:50
Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
Fahad Khaliq, Doctor of Medicine at Allied Hospital, Faisalabad, reposted from Muhammad Moor on X:
”Faster, potent, better, reversible, better mortality results
But here’s the plot twist!
If a patient is already on anticoagulation/high risk bleed, Clopidogrel is preferred
Rule of thumb:
• STEMI pt undergoing PCI: Ticagrelor
• STEMI pt undergoing Thrombolysis: Clopidogrel”
Quoting Muhammad Moor‘s post:
”Why is Ticagrelor sometimes preferred over other antiplatelets in acute coronary syndrome (ACS)?”
Stay updated with Hemostasis Today.
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS
-
Apr 9, 2026, 21:29Satyam Arora: Improving Thalassaemia Care in India Through Ground-Level Data
-
Apr 9, 2026, 20:33Pat Garcia-Gonzalez: On World Health Day, I’m thinking about what ‘health’ really means.
-
Apr 9, 2026, 19:13Jan Sloves: Patterns and Pitfalls Influencing Treatment of Small Saphenous Vein Reflux
-
Apr 9, 2026, 18:38Jecko Thachil: Why D-dimers are Useful Tests for the Exclusion of Thromboembolism and the Diagnosis of DIC